Navigation Links
PAREXEL Consulting Thought Leaders Provide Insights Into U.S. Biosimilar Development and Monoclonal Biosimilars in Two New White Papers
Date:9/22/2010

ated with: actual operating performance; actual expense savings and other operating improvements resulting from recent and anticipated restructurings, the loss, modification, or delay of contracts which would, among other things, adversely impact the Company's recognition of revenue included in backlog; the Company's dependence on certain industries and clients; the Company's ability to win new business, manage growth and costs, and attract and retain employees; the Company's ability to complete additional acquisitions and to integrate newly acquired businesses or enter into new lines of business; the impact on the Company's business of government regulation of the drug,  medical device and biotechnology industry; consolidation within the pharmaceutical industry and competition within the biopharmaceutical services industry; the potential for significant liability to clients and third parties; the potential adverse impact of health care reform; and the effects of exchange rate fluctuations and other international economic, political, and other risks.
Such factors and others are discussed more fully in the section entitled "Risk Factors" of the Company's Annual Report on Form 10-K for the year ended June 30, 2010 as filed with the SEC on August 27, 2010, which "Risk Factors" discussion is incorporated by reference in this press release.  The Company specifically disclaims any obligation to update these forward-looking statements in the future.  These forward-looking statements should not be relied upon as representing the Company's estimates or views as of any date subsequent to the date of this press release.

PAREXEL is a registered trademark of PAREXEL International Corporation, and Perceptive Informatics is a trademark of Perceptive Informatics, Inc. All other names or marks may be registered trademarks or trademarks of PAREXEL International Corporation, Perceptive Informatics, Inc. or their respective owners and are hereby acknowledged.Co
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. PAREXEL Announces Strategic Functional Service Provider Relationship with Eli Lilly and Company for Clinical Development in Asia/Pacific Region
2. PAREXEL Introduces Temperature Recording Solution for Study Drug Transportation, Bringing More Efficiency to Clinical Supply Chain
3. PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference
4. PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument
5. PAREXEL Reports First Quarter Fiscal Year 2010 Financial Results
6. PAREXEL International to Present at William Blair Emerging Growth Stock Conference
7. PAREXEL Reaches Milestone in Management of Oncology Trials Over Last Five Years Involving 175,000 Patients Worldwide
8. PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru
9. PAREXEL Data Reveal A Record High Number of Clinical Trials Initiated
10. PAREXEL Expands Global Clinical Pharmacology Capabilities
11. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Dec. 24, 2014 /PRNewswire/  -- Tianyin Pharmaceutical Inc. ... company that specializes in the patented biopharmaceutical, modernized ... pharmaceutical ingredients (API) released unaudited preliminary financial results ... Fiscal Year 2015 Ended September 30, ... million compared with $14.7 million in 1Q14 with ...
(Date:12/24/2014)... -- The International Trade Commission (ITC) issued its final decision in ... a notice issued on December 23, the ITC ruled in ... humidifier was invalid. BMC President, James Xu ... excited with the ITC,s decision in this case. This victory ... the very beginning on the key patents in the case. ...
(Date:12/24/2014)... FARMINGTON, Conn. , Dec. 24, 2014 ... a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics ... medical need and commercial potential, today announced that ... 2,050,000 shares of its common stock and Series ... common stock.  Funds under the management of QVT ...
Breaking Medicine Technology:TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 2TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 3TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 5TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 6TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 7TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 8TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 9TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 10TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 11TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 12ITC Final Decision Goes Against ResMed (RMD) Monumental Win for 3B/BMC 2Palatin Completes $20 Million Equity and $10 Million Debt Financings 2Palatin Completes $20 Million Equity and $10 Million Debt Financings 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 4
... SEATTLE, Jan. 31, 2012 /PRNewswire-iReach/ -- Today ... the launch of new last mile postal service delivery ... software. In addition to existing support of multiple global ... cost-effective delivery capabilities to businesses and residences in over ...
... 2012 Vystar Corporation (OTCBB: VYST), the exclusive ... third US and first Chinese patent for its ... five issued patents in the US and abroad that relate ... (Logo: http://photos.prnewswire.com/prnh/20100203/CL48049LOGO ) The new ...
Cached Medicine Technology:Enroute Adds Last Mile Postal Service Delivery Services 2Enroute Adds Last Mile Postal Service Delivery Services 3Vystar® Corporation Receives its Third US Patent and First Chinese Patent for Vytex® Natural Rubber Latex 2Vystar® Corporation Receives its Third US Patent and First Chinese Patent for Vytex® Natural Rubber Latex 3
(Date:12/24/2014)... York (PRWEB) December 24, 2014 ... ) that allege the blood thinner caused life-threatening ... outlined a leadership structure for the proceeding, Bernstein ... December 17th, the Court plans to select lawyers ... and also plans on appointing a Plaintiffs’ Steering ...
(Date:12/24/2014)... 2014 Mike Billings , PT, ... Derek Fenwick, PT, MBA, GCS, Director of Professional ... from the passing of the Improving Medicare Post-Acute ... this taping of the Infinicast, the two leaders discuss ... Social Security Act to standardize post-acute assessment data for ...
(Date:12/24/2014)... -- Hepatitis C infection does not contribute to mental decline ... Treatment advances have made it possible for people with HIV ... problems, mood swings and other types of mental impairment as ... long-term infections with other viruses -- a common problem in ... the prime suspects has been the hepatitis C virus, which ...
(Date:12/24/2014)... HealthDay Reporter WEDNESDAY, Dec. ... to start smoking or drinking with each additional symptom ... disorder, new research suggests. "Our findings underscore ... substance use as [these] children approach adolescence," said study ... Research Group, which is part of Cincinnati Children,s Hospital. ...
(Date:12/24/2014)... (PRWEB) December 24, 2014 For chic ladies, ... year. As a part of their Holiday Wish List, ... highlight as perfect ways to accent ladies’ holiday wardrobe by ... Ladies should be all over the discount of 80% off, ... and ready to ship. The company’s chic wedding dresses are ...
Breaking Medicine News(10 mins):Health News:Court Overseeing Federal Xarelto Lawsuits Issues Coordination Order, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal Xarelto Lawsuits Issues Coordination Order, Bernstein Liebhard LLP Reports 3Health News:Latest Episode of Infinicast Features Infinity Rehab President Discussing IMPACT Act of 2014 and Changes for Post-Acute Therapy Providers in 2015 2Health News:Hepatitis C Infection Isn't Related to HIV Brain Woes: Study 2Health News:ADHD May Raise Teens' Odds for Smoking, Drinking 2Health News:ADHD May Raise Teens' Odds for Smoking, Drinking 3Health News:Angeldress.co.uk Starts Its Big Sales by Offering Various Kinds of Cheap Clothes and Fashion Accessories 2
... medications are at an increased risk of falling in the ... dose increase of their current drug, according to a new ... an affiliate of Harvard Medical School., Published online in the ... that nursing home residents have a fivefold increased risk of ...
... in California hospitals to similar hospitals in the U.S. ... Pennsylvania School of Nursing have found that controversial legislation ... hospital staffing mix, not fewer as feared. , ... staffing levels. However, mindful of the ongoing nurse shortage ...
... July 15 (HealthDay News) -- Injection drug users have ... what types of drugs they use, according to a ... higher rates of abuse, dependence and other physical and ... programs specialize their care to target these high-risk individuals. ...
... of consent forms provided to volunteers for HIV/AIDS research ... risks and benefits has found that the forms were ... complex enough to hinder full understanding, according to bioethicists ... of 124 informed-consent documents for U.S. government-sponsored, multinational HIV/AIDS ...
... Rome (July 15, 2011): The Lancet , a leading ... the critical role of expanding access to HIV treatment under ... , The publication of the editorial comment coincides with ... Treatment and Prevention (IAS 2011) taking place in Rome, Italy ...
... An international team of researchers has identified two genetic regions ... Restless legs syndrome is a condition in which people experience ... only by movement. One of the most common neurological diseases, ... and even depression. In the new study, scientists ...
Cached Medicine News:Health News:Nursing home residents at heightened risk of falling in the days following 2Health News:California nurse staffing 2Health News:Injection Drug Users Most in Need of Treatment, Study Says 2Health News:Informed-consent forms should be shortened, simplified, Johns Hopkins bioethicists confirm 2Health News:Informed-consent forms should be shortened, simplified, Johns Hopkins bioethicists confirm 3Health News:Roll out treatment as prevention now to stop HIV and AIDS 2
... comprehensive line of pregnancy tests including rapid ... convenient one-step stick and cassette formats. The ... Easy HCG is a 25 mIU urine ... HCG II provides 25mIU sensitivity for ...
... Wampole Laboratories offers a comprehensive line ... for serum and urine in convenient one-step ... offers 2 testing options. Clearview Easy HCG ... a convenient stick format. Clearview HCG ...
... hemolyzed preparation of whole blood is mixed ... binding cation-exchange resin. During this time, HbAo ... period. a filter separator is used to ... which contains glycohemoglobin. The percent glycohemoglobin is ...
... is the main storage protein for iron. ... shell (apoferritin) composed of heavy and light ... iron oxide and phosphate [1]. Ferritin is ... other body tissues, with major concentrations found ...
Medicine Products: